1.	A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma Phase: Phase III, Phase II Type: Treatment Status: Completed Age: 18 to5 Sponsor: Pharmaceutical / Industry Protocol IDs: 1839IL/0143, NCT00234429
2.	Phase II Study of ICI D1694, a Thymidylate Synthase Inhibitor, in Patients with Pancreatic or Gastric Adenocarcinoma (Summary Last Modified 07/93) Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: MSKCC-93019, NCI-V93-0246
3.	Phase II Study of ICI D1694 (a Thymidylate Synthase Inhibitor) in Patients with Recurrent, Platinum-Sensitive Ovarian Epithelial Cancer (Summary Last Modified 08/95) Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: GOG-146B
4.	Phase II Study of ICI D1694 (a Thymidylate Synthase Inhibitor) in Patients with Advanced Gastric or Pancreatic Adenocarcinoma (Summary Last Modified 08/93) Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Protocol IDs: NCI-93-C-0164, NCI-NMOB-9301
5.	Phase I Study of ICI D1694 in Adult Patients with Solid Tumors (Summary Last Modified 11/92) Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-91-C-177D, NCI-MB-275, NCI-T91-0121N, T91-0121